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Abstract
Background: The use of the knowledge produced by sciences to promote human health is the main goal of
translational medicine. To make it feasible we need computational methods to handle the large amount of
information that arises from bench to bedside and to deal with its heterogeneity. A computational challenge that
must be faced is to promote the integration of clinical, socio-demographic and biological data. In this effort,
ontologies play an essential role as a powerful artifact for knowledge representation. Chado is a modular
ontology-oriented database model that gained popularity due to its robustness and flexibility as a generic platform
to store biological data; however it lacks supporting representation of clinical and socio-demographic information.
Results: We have implemented an extension of Chado – the Clinical Module - to allow the representation of this
kind of information. Our approach consists of a framework for data integration through the use of a common
reference ontology. The design of this framework has four levels: data level, to store the data; semantic level, to
integrate and standardize the data by the use of ontologies; application level, to manage clinical databases,
ontologies and data integration process; and web interface level, to allow interaction between the user and the
system. The clinical module was built based on the Entity-Attribute-Value (EAV) model. We also proposed a
methodology to migrate data from legacy clinical databases to the integrative framework. A Chado instance was
initialized using a relational database management system. The Clinical Module was implemented and the
framework was loaded using data from a factual clinical research database. Clinical and demographic data as well
as biomaterial data were obtained from patients with tumors of head and neck. We implemented the IPTrans tool
that is a complete environment for data migration, which comprises: the construction of a model to describe the
legacy clinical data, based on an ontology; the Extraction, Transformation and Load (ETL) process to extract the data
from the source clinical database and load it in the Clinical Module of Chado; the development of a web tool and a
Bridge Layer to adapt the web tool to Chado, as well as other applications.
Conclusions: Open-source computational solutions currently available for translational science does not have a
model to represent biomolecular information and also are not integrated with the existing bioinformatics tools. On
the other hand, existing genomic data models do not represent clinical patient data. A framework was developed
to support translational research by integrating biomolecular information coming from different “omics”
technologies with patient’s clinical and socio-demographic data. This framework should present some features:
flexibility, compression and robustness. The experiments accomplished from a use case demonstrated that the
proposed system meets requirements of flexibility and robustness, leading to the desired integration. The Clinical
Module can be accessed in http://dcm.ffclrp.usp.br/caib/pg=iptrans.
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Background
Translational medicine deals with the application of
basic research results, especially those coming from
“omics” technologies to help in health and disease pro-
cesses [1]. This new area of research seeks to reduce the
existing gap between the bench and the bedside. This is
a big challenge that has many barriers to be overcome
and one of the most important is related to the diversity
of data. The nature of clinical data is very different from
the nature of molecular data, although they are often
closely related.
Another significant aspect is that in many cases there
is no consensus about what kind of information is most
useful and therefore important to relate [2], and there
are distinct needs of information for each case, i.e. the
kind of information is heterogeneous. Thus, a generic
and flexible model tends to be more appropriate. Taking
as an example a cancer project that includes several re-
search groups, it is expected that there is a disparity be-
tween the databases derived from each project. Thus, to
analyze data coming from these sources, it is necessary a plat-
form that processes an effective data integration. In addition,
this platform should allow the creation of new types of data
easily, to attend the diversity of researchers’ needs.
A global analysis concerning different levels of infor-
mation is necessary when studying complex mechanisms
responsible for the onset of pathological processes. To
make it possible, two major aspects of data handling
must be well defined and mastered: storage and analysis.
It is necessary to provide a computational platform and a
data model able to store, represent and integrate clinical
and biomolecular information in a consistent way. From a
well formalized and structured model it is possible to de-
sign consistent methods for computational analysis.
In translational science there are some computational
platforms to store and retrieve clinical data. Slim-Prim
(Scientific Laboratory Information Management –
Patient-care Research Information Management) is an
integrated data system for collecting, archiving and dis-
tributing basic and clinical research data. Slim-Prim is
hosted at the University of Tennessee and provides an
open-source version called PRIME [3]. Although Slim-
Prim and PRIME claim to allow the management of
microarray data information, DNA sequencing informa-
tion and other biomolecular data, they don’t provide in-
tegration to any bioinformatics tools and, at the time,
this data are treated like a generic data type.
STRIDE (Stanford Translational Research Integrated
Database Environment), developed at Stanford Univer-
sity, is a standard-based platform to support clinical and
translational research [4]. It consists of three compo-
nents: a clinical data warehouse, based on HL7 RIM
(Health Level Seven - Reference Information Mode), a
semantic model based on ontologies (such as SNOMED,
ICD and RxNorm) and a framework to build research
management applications. Currently there are no plans
to implement STRIDE outside Stanford.
The NIH NCBC (National Institutes of Health - National
Center for Biomedical Computing) I2B2 (Informatics for
Integrating Biology and the Bedside) is responsible for
building applications to manage project-related clinical data
in the genomic era [5]. I2B2 Hive is a framework composed
of software modules to computationally support clinical
research [6]. Each software module is called a “Cell” and
each Cell can communicate with each other through Web
Services. The main modules are responsible for data stor-
age, ontology management, identity management and
others. Although I2B2 Hive is a powerful scalable tool to
manage clinical information, it does not have a Cell to rep-
resent or to analyze biomolecular data such as microarray
or nucleotide sequence data.
In the area of genomics there are several databases of
specific organism, disease or biological process and some
models of biological databases such as AceDB, Ensembl
and Chado that are organism-independent. These spe-
cific databases also include analytical tools specific for
the problem addressed. CerealsDB [7] is a database of
genomic information about wheat. IBDsite [8] is a plat-
form to aggregate and analyze biomolecular data in-
volved in inflammatory bowel diseases (IBD). IPAD [9]
and Atlas [10] are more general approaches because they
aggregate data from several public genomic databases
such as KEGG, GenBank, and Uniprot.
On the other hand, there are biological databases
models that are the basis for building computational
tools for genomic analysis under an organism-independ-
ent way. AceDB (A C.elegans Database) [11] is one of
the pioneering models for biological databases. It con-
sists of a hierarchical schema of Database Management
System (DBMS) and was initially built to support re-
search about C. elegans (subsequently adapted to other
organisms). It is based on an integrative approach and
can be used to represent many other types of informa-
tion, including those unrelated to biology. Ensembl [12]
was initially developed to support human genome re-
search and currently support more than 45 genome spe-
cies. It consists of several computational tools such as
EnsMart [13], a biological data warehousing tool for in-
tegration and query of biological data.
A model of biological databases which have gained
popularity among research groups devoted to different
organisms is Chado [14]. It is a robust, flexible and gen-
eric platform that can be adapted to support research re-
lated to several organisms. It consists of a modular
schema of a relational database that can be adapted and
extended. An essential feature of Chado, which differs
from the other biological database models is that it is
ontology-oriented. Ontologies are structural artifacts
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used for the representation and integration of knowledge
in many domains. Ontologies vary from simple vocabu-
laries, used to standardization of terms, to fully concep-
tual models that enable reasoning and knowledge
discovery. Chado, as well as those other biological data-
bases, does not have a module to store clinical and
socio-demographic information.
In this context, we are presenting the definition of a
computing framework that aggregates clinical and biomo-
lecular data in a consistent way, allowing the development
of computational analysis to be applied in the field of
translational medicine. To guarantee standardization and
enable further development of generic tools for data ana-
lysis we propose the use of a common reference ontology.
We consider to use the Chado model as the basic
genomic data model to propose the design and imple-
mentation of a new module to store clinical and socio-
demographic information, in order to assist procedures
and research in translational medicine. Chado was
chosen because it is a flexible, robust and ontology-
oriented model.
Ontology-anchored approaches have been used suc-
cessfully to query and integrate data in the clinical and
biological domain. CDAO-Store [15] is a computational
tool that uses the Comparative Data Analysis Ontology
to facilitate the storage and retrieval of phylogenic data.
Borlawsky et al. reports a proof of concept information
retrieval tool called Research-IQ [16], which enables re-
search to query heterogeneous datasets. This approach
uses free-text that is mapped to concepts related to
osteoarthritis. Payne et al. [17] proposes an approach
called Constructive Induction to enable the reasoning
over a knowledge repository aimed to discover poten-
tially informative biomarker-to-phenotype relationship.
We propose the use of a common reference ontology
(Translational Medicine Ontology) to allow data integra-
tion through terminology standardization, and to support
the development of generic analytical tools. As a use case
we have tested our framework to aggregate data from the
project “Oncogenomics Applied to Therapy of Head and
Neck Carcinoma” sponsored by Brazilian GENOPROT
Network (CNPq). Through this framework it is possible to
integrate sequence data, gene expression data from micro-
array, microRNA and disease association data with the
clinical and socio-demographic features of patients who
provided samples for laboratory test generation.
Methods
The proposed platform is divided in four levels: data
level, semantic level, application level and web interface
level (Figure 1). In data level we use the Chado model as
the basic genomic data model and we have created a
new module to store clinical information (Clinical
Module - CM). The semantic level consists of the
ontologies that represent the clinical databases and a
common reference ontology that acts as a conceptual
framework. The application level is composed of a set of
modules, written in Perl language, that are responsible
for the management of the clinical databases, ontologies
and data integration process. A web interface allows the
interaction between the system and the user. This inter-
face is implemented using the Catalyst Model-View-
Controller (MVC) Framework.
We also propose a migration methodology to be ap-
plied on legacy clinical databases and an ontological
mapping that allows data standardization, integration
and development of generic analysis tools.
Data level
The data level is responsible for storing the data. It is
composed of a database management system implemen-
ting the Chado data model. We implement the proposed
Clinical Module in this level, since Chado has the rela-
tions to represent biomolecular data, but does not repre-
sent clinical data.
Chado
Mungal, Emmert and the Flybase group proposed a
modular design based on ontology to represent bio-
logical information, called Chado [14]. Chado is a rela-
tional database schema that can be used as a basis for
any group of genomic research. Chado is part of GMOD
(Generic Model Organism Database) project [18] and is
currently used by several research groups such as
Xenbase [19], ParameciumDB [20], AphidBase [21],
BeetleBase [22], among others.
Chado is composed of eighteen modules. Each module
is defined as a set of tables, triggers and functions re-
sponsible for managing information from a subdomain
of genomics. Five out of these modules are the core of
Figure 1 Levels of the integrative platform for translational
research. In the data level, the green boxes represent the existing
Chado modules such as: Cv, controlled vocabulary module and
MAGE, microarray gene expression module; the blue box represent
the proposed Clinical Module (CM). The semantic level is composed
mainly by the clinical database models and the common reference
ontology. In the application level there are the Perl modules that
implements the business logic. Perl MVC Framework Catalyst
implements the user interface level.
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Chado. Chado is extensible because it allows the incorp-
oration of new modules and, if necessary, amendments
to existing modules.
One hallmark of Chado in relation to other generic da-
tabases models is that it makes intensive use of ontol-
ogies. Ontology plays a central role in Chado, because
all stored information must be related to some ontology
or controlled vocabulary. Some ontologies are already
incorporated into Chado such as the Sequence Ontol-
ogy, which is used to describe types of nucleotide
sequences and the OBO (Open Biomedical Ontologies) -
Relation Ontology, which is used to describe relation-
ships. But it is possible to incorporate new ontologies
described in OWL (Web Ontology Language) [23] or in
OBO-Format [24].
There are computational tools compatible with Chado
databases. These tools are mostly provided by the
GMOD group. We can mention the genome browser
GBrowse [25] and the Apollo [26] annotation tool.
Chado also allows incorporation of other tools through
the creation of Bridge Layers which consist of built
views to make Chado similar to other databases and act
as layers for compatibility with other tools.
Proposed clinical model
Chado has the Stock Module which allows representa-
tion of stock collection in a laboratory. This concept of
‘stock’ can be generalized to represent strain, line, bio-
logical entities or individual, therefore it could represent
patients. The Natural Diversity Module [27] allows rep-
resentation of experiment data related to a stock, there-
fore this module allows to represent clinical information
as experiments. However, this approach could make it
harder the process of clinical data integration from dif-
ferent sources and would preclude the generation and
the use of the Clinical Databases bridge layers. More-
over, we think it’s very important to keep a higher level
of semantics associated with the tables that are being
used. Thereat, and also because of the inherent com-
plexity associated with clinical information, we choose
to develop a new Clinical Module. This data model, pro-
posed in this work as a new module of Chado, is shown
in Figure 2. An ontology stored in the Controlled
Vocabulary (CV) module of Chado defines the semantics
of the clinical data stored in this module. This ontology
could be any one of those belonging to the biomedical
domain, representing the concepts of the clinical data.
Figure 2 Chado clinical module. In green: tables from Controlled Vocabulary module. In pink: tables from the General Module. In blue: tables
from the proposed Clinical Module.
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The proposed module was designed to be a flexible
and generic tool for representation of legacy clinical
databases. In Figure 2, the pink table comes from the
General Module of Chado, the green tables come from
Controlled Vocabulary Module and the blue tables make
up the proposed Chado Clinical Module.
The clinical module was built based on the Entity-
Attribute-Value (EAV) model. In EAV model the infor-
mation is represented as a tuple of 3 itens: 1) the entity,
an identifier of the item or individual which is been de-
scribed; 2) the attribute, the feature described about the
item; 3) the value, which is the value of that feature ap-
plied to the individual. EAV model is best applied mainly
when data is sparse, highly heterogeneous, the number
of attributes is large and new attributes are often needed.
This is the case of clinical data repository or research
databases especially those dealing with a large range of
medical specialties [28].
The Clinical Module is composed of seven tables:
patient, patientprop, appointment, project_cdb, csd,
csd_relationship and csdprop. The patient table is self-
described, it is where the patients data are stored. Chado
already has a project table, which defines a context
grouping a set of related information such as a set of as-
says in a study. Since each patient belongs to a clinical
database and each clinical database can be linked to
many projects, we created the table project_cdb.
The clinical or socio-demographic information that do
not change over time or that do not require a temporal
record (e.g. sex, birthdate, address), are stored in the
table patientprop.
The types of clinical or socio-demographic information
(such as age, weight, tumor size, type of tumor) are repre-
sented by an ontology that is stored in the Controlled
Vocabulary Module, particularly in cv and cvterm tables.
The csd (clinic-social data) table is where most of the
information is stored. This table was designed to repre-
sent, in a flexible way, any kind of clinical or socio-
demographic information related to a patient. The
patient’s information is linked through the patient_id
column. The semantics of the clinical information is
given in column type_id that is a foreign key to column
cvterm_id in cvterm table which stores the terms of the
ontology that represent the types of clinical and socio-
demographic information. The column value holds the
content of information. The column rank is used when
it is necessary to store the same type of information to
the same patient. For each instance of that information,
the column rank receives a new value. Another import-
ant column is parent_csd, which is a self-relationship.
This column is used to represent information related to
another patient clinical data.
The csdprop table is responsible for storing patient-
independent information. Usually this kind of data is
stored in tables that are referenced by foreign keys in
patient table or in any patient-dependent table, for
example information about cities, drugs, hospitals, pro-
cedures, etc. This kind of information exists regardless
of the patients.
The table csd_relationship is used when it is necessary
to represent complex relationships between clinical or
socio-demographic data. In this table it is possible to
link two clinical information, using columns subject_id
and object_id which are foreign keys of csd table,
through a relationship given by the column type_id,
which is a foreign key of cvterm table.
Semantic level
The Semantic Level is composed of a set of ontologies
and database models. According to Rubin et al. [29], on-
tologies can be a wide variety of computational artifacts
such as: terminologies, thesaurus, controlled vocabular-
ies, information models and formal defined ontologies
themselves. We can classify the models stored in the se-
mantic level in three different ways:
 Clinical Database Model: these models will describe
the structure of a clinical database. In order to do
this, it is necessary to represent the tables and their
corresponding columns. The model has three levels:
the first is the generic element root which, by
convention, is the name of the legacy database; the
second level is composed of the tables; and in the
third level the columns linked with their respective
table are represented (Figure 3).
 Domain Ontologies: ontologies that represent
concepts from a specific domain of interest, e.g.:
ICD, SNOMED, Translational Medicine Ontology
and Gene Ontology.
 Common Reference Ontology: it is an ontology used
to integrate the clinical information from different
Clinical Database Models. It can be composed of
one or more domain ontologies. This ontology is
used like a conceptual framework where the
information is integrated through ontological
Figure 3 Clinical database model representation. Three-level
model: first level is a root element representing the clinical database,
second level is made up by the tables and third level by
the columns.
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mappings between concepts of a clinical database
model and the common reference ontology.
Application level
The application level is composed of a set of modules
responsible for creating, updating, retrieving and man-
aging information. These modules are written in Perl
language to facilitate the integration with tools built to
work with Chado.
User interface level
Catalyst is the Perl MVC Framework for building web
applications [30]. It is possible to design and implement
web application in a modular, maintainable and testable
manner. We have used Catalyst to implement the web
user interface level. It resulted in a tool called IPTrans
(Integrative Platform for Translational Research), whose
query interface is shown in Figure 4. Besides supporting
the management of clinical and socio-demographic in-
formation, this application also supports the manage-
ment of projects, microarray assays and biomaterials.
Proposed migration methodology
We have developed a methodology to migrate data from
legacy sources to the Clinical Module. The data sources
can be of different types, such as relational databases,
comma-separated values (CSV) files or SQL dump files.
The methodology consists of four steps:
Step 1. Create the clinical database model
This step consists of the creation of a model to describe
the clinical database (CDB) which houses the original
data, as described in the Semantic Level section.
Step 2. Store the clinical database model on chado
Since the clinical database model is structured in a hier-
archical way, it can be represented as a basic ontology.
There are several ways to store the created ontology in
Chado. It depends on the language used for representa-
tion. The most common ontology representation
languages are OWL (Web Ontology Language) and
OBO-Format (Open Biomedical Ontologies). A simple
way is to use the Perl scripts provided with Chado. The
clinical database model is represented mainly in the
Chado tables cv and cvterm.
Step 3. Store the data in the clinical module
In order to migrate the data stored in the legacy clinical
database to the Clinical Module in Chado, it is necessary
to plan an ETL (Extraction, Transformation and Load)
process. In this step, it is important to maintain the cor-
rect “typing” information according to the ontology of
clinical database stored in the CV module. In other words,
it is necessary to correctly relate the information stored
with the respective term of the clinical database model.
Step 4. Create the clinical database bridge layer
The bridge layer consists of a set of views that represent
the structure of the clinical research database through
Chado. The advantage of creating the Bridge Layer is the
facility to query and to adapt the analytical tools that
were designed for the clinical database to work correctly
on Chado.
The migration methodology proposed here can be
used to adapt legacy clinical databases to the proposed
framework. This methodology can be applied to data in
relational database, comma-separated files and sql dump
files. The integration occurs when the ontologies of the
clinical sources are mapped to a common reference
ontology.
Figure 4 Web user interface. Print screen of the query tool interface.
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Ontological mapping
The key advantages of the developed platform are the
flexibility and the generality to represent information.
On the other hand, the proposed structure does not de-
fine the meaning of the stored information. The infor-
mation stored in clinical databases could be represented
using specific ontologies that capture the meaning of
data in the particular database. But to get the most out
of this generic model, allowing the development of ana-
lytical tools that could be applied in different instances
of Chado with data descending from different clinical
databases, it is necessary to define a common semantic.
This can be done by adopting a reference ontology, so
the analytical tools could be designed to get semantic in-
formation from the reference ontology. The work then
consists of ontological mapping between the model that
describes the clinical database and the reference ontol-
ogy (Figure 5).
In the following, we formally define the notion of the
ontological mapping environment and the rule of the
common reference ontology.
Definition: An ontological mapping environment is a
5-tuple concept: OME = (CRO, Sk, SMk, Mk, m), k=1..n,
where:
 CRO is the common reference ontology, which is a
domain ontology that represents general concepts
from biomedical domain, acting as a mediated
schema. The set of ‘p’ concepts and ‘q’ relations of
CRO are defined as C1,…,Cp and R1,…,Rq
respectively.
For each k = 1,…n
 Sk: is a source schema, representing the schema of a
clinical source. Examples of clinical sources are
tabular files, SQL dump files and relational
databases. Each source is composed by a set of ‘r’
entities defined as E1,…,Er.
 SMk: is the source model, that uniquely and
formally describe Sk using a simple hierarchy of
terms. SMk is composed by a set of ‘r’ terms defined
as T1,…,Tr. Each term represents an entity of Sk.
 Mk: is the set of mapping relations that are defined
between SMk and CRO. Each mapping relation ‘m’
is defined as an exact match between a Ci and Ti.
Mk is composed by ‘o’ mapping relations where o ≤ r.
 M: is defined as the set of all Mk, in other words, it
corresponds to all mapping relations between all
SMk and the CRO.
In this work we propose the use of Translational
Medicine Ontology (TMO) [31] with mappings to the
ACGT (Advance Clinico-Genomics Trials on Cancer)
Master Ontology [32] as the common reference
ontology.
TMO is an ontology built by the Healthcare and Life
Sciences (HCLS) interest group in the W3C Semantic
Web. TMO aims to represent general concepts related
to translational medicine. It is based on three external
ontologies: Basic Formal Ontology, Relation Ontology
and Information Artifact Ontology. TMO also have
mappings to about other 40 ontologies, e.g. TMO is
mapped to the ACGT Master Ontology. The ACGT
Master Ontology is an ontology dedicated to cancer re-
search and has been developed in the context of the
ACGT project.
The use of TMO with mappings to the ACGT Master
Ontology enables the representation of general concepts
in the area of translational medicine and it has achieved
a greater specificity in the field of oncology allowing rep-
resentation with greater granularity of information in
this area. Through TMO it is possible to extend the
platform to other areas of translational medicine using
one of the ontologies already mapped to TMO or by
extending it.
Data integration
The user can obtain the integrated data in two different
ways through a query tool: the user defines a set of pa-
tients based on clinical or socio-demographic character-
istics and then the tool outputs the related biomolecular
information, such as the gene expression from micro-
array experiments. The other way is opposite: from a
selection of biomolecular information it is possible to
obtain the clinical or socio-demographic information re-
lated to the set of patients that originated that biomolec-
ular information. This integrated data set can be used in
a user-defined analysis or data mining algorithms can be
adapted to search for associations between the biomo-
lecular and clinical information (Figure 6).
Figure 5 Ontological mapping between clinical databases
models and the reference ontology. Diagram representing the
process of ontological mapping. First the clinical database models
are created from the clinical data sources and then each element is
mapped to a reference ontology.
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The integration between clinical information and gene
expression information in Chado occurs by the link
between the tables patient and biomaterial. The bioma-
terial table is part of the MAGE Module and is respon-
sible for representing some biological material such as
tissue, cells and serum. The patient identification is
stored as a property of the biological material in the
biomaterialprop table. The assay table represents a
hybridization. The link between the biomaterial and the
expression information occurs in assay_biomaterial
table which maps each biomaterial that is used in each
hybridization. In that way, it is possible to associate ex-
pression information with clinical or socio-demographic
patient data.
Results
Use case
To test the proposed framework we have implemented
an instance of Chado using the DataBase Management
System PostgreSQL 8.4 [33]. We also have implemented
the proposed Clinical Module.
We have tested the functionality of this approach with
success with data from the project “Oncogenomics
Applied to Therapy of Head and Neck Carcinoma” from
GENOPROT Network (CNPq - Brazil), whose informa-
tion is stored in the database of Clinical Genomics
Project, which is part of the Ludwig/FAPESP Human
Cancer Genome Project. This project aims to carry out
joint research focused on the analysis of genetic and epi-
genetic mechanisms responsible for regulating the tran-
scriptome and secretome in head and neck carcinomas.
This research focus on searching for biomarkers for
diagnosis and prognosis to allow the use of them as
therapeutic targets.
Clinical and demographic data were obtained from
patients with tumors of head and neck through the
Service of Head and Neck Surgery in School Hospital of
Faculty of Medicine (SH-FM) of University of São Paulo,
at Ribeirão Preto, Brazil. These patients provided the
biomaterial for the assays.
A Chado instance was installed on the relational
DBMS PostgresSQL. The clinical database has about 20
tables with some of them containing up to 120 columns.
The main table stores information about the patient like
age, sex, weight and height. The legacy clinical informa-
tion was stored in a MySQL [34] relational DBMS.
To implement the first step, by building the clinical
database model, based on an ontology, we have used the
ontology editor OBO-Edit [35] with the knowledge rep-
resentation language OBO-Format.
During step 2, we loaded the ontology using Perl
scripts provided with Chado.
Figure 7-a shows part of the structure of the patient
table in clinical database (CDB) and how this informa-
tion was stored in the Chado CV module after the ontol-
ogy loading. The first step consists in representing the
patient table and the respective columns such as ‘age’,
‘height’ and ‘weight’ by an ontology and then load this
ontology in Chado CV Module. This is done specifically
in cv table, where the ontologies are stored, and in
cv_term table, where the ontology terms are stored.
In step 3, we have built an ETL process, which
consisted in: extracting the data from the clinical data-
base; transforming the information provided (when ne-
cessary); and loading this data in the Clinical Module of
Chado. This process was built through the definition of
a set of functions in PL/pgSQL. Figure 7-b illustrates
how the original information from clinical database can
be stored in Chado. In this example, the data extracted
Figure 6 Example workflow for the generation of integrated data. Diagram representing two ways of how to generate integrated data.
Selecting a group of patients using the reference ontology concepts or selecting a set of experiments using filters with biological conditions.
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from a specific patient are age, height and weight. First, a
record in the patient table of Chado Clinical Module is
created, and this record receives an internal identifier
(in this example, it would be the id “9”). Then, the clin-
ical data and demographic data from this patient as well
as the clinical database identifier are stored in the table
csd of the Clinical Module. This information will be dif-
ferentiated from each other through the column type_id,
that is foreign key of column cvterm_id from table
cv_term, which stores the clinical databases ontology. Each
piece of information stored in the table csd is “typed”, in
other words, is semantically represented by the clinical
database model stored in clinical CV Module.
To represent part of the information from the clinical
database we used the columns rank and parent_csd. The
column rank received a serial value and was used when
we stored the same type of information (same type_id)
for the same patient. A sample case is when we wanted
to store the drugs taken by a patient (suppose
Carboplatin, Decadron and Furosemide). In this case,
the tool automatically created three records in the table
csd for the same patient (same patient_id) and with the
same type_id (cvterm referenced the term "drug"), so
each drug is distinguished by a different value of rank.
The column parent_csd represents a self-relationship.
It was used to store the dosage of the drugs, suppose
Carboplatin, one of the drugs that were mentioned in
the previous paragraph. To relate the information of
dosage to the right drug, we used the column
parent_csd. Figure 7-b also illustrates the structure and
content of the table csd for the discussed example.
Finally, a Bridge Layer for the clinical database in
Chado was built, together with a web tool to run on the
CDB information management database. The Bridge
Layer adapts the web tool to Chado, as well as other ap-
plications (Figure 8).
The Bridge Layer could be built for other databases
through a portion or all information stored in the clin-
ical module. Thus, other tools and applications built for
other databases could be used without recoding.
Limitations and future work
The proposed computational platform, yet flexible and
generic has some limitations: the clinical module is not
the best choice to implement hospital common daily
procedures such as hospital bed control, drug control,
billing and scheduling appointments. The flexibility and
generality of the clinical module, which are important in
the process of data integration, make the implementa-
tion of these functionalities complex and costly. Another
issue is the loss of performance in queries over the
bridge layer. This happens because the views that com-
pound the bridge layer are built through pivoting the
table that follows the EAV model, i.e., the transformation
Figure 7 Integrating the model and the content of a clinical database into Chado CV and clinical module. Clinical database
representation and integration workflow: a) Clinical database models are generated and loaded into Chado Controlled Vocabulary Module;
b) Data are imported into Clinical Module, mainly in table csd which follows the EAV structure of information representation.
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of row modeled data to column modeled. One way to
solve this is the materialization of the views that make
up the bridge layer. In this solution the data become re-
dundant but there is a performance gain that is higher
as the number of columns that compound the view. This
same problem occurs in the ad hoc query tool. In this
case the materialization is not a good strategy because
the queries vary widely. Then, we applied the solution
proposed by Dinu and Nadkami [28] which consists of
breaking a big query into smaller and simple queries and
accomplish the union or intersection of the results.
Much remains to be done to meet the computing
needs of translational research. Future work can be
divided into two contexts: data integration and clinical
issues.
In the context of data integration, implementation of
entity resolution algorithms would allow identification of
the same entity in different databases that are integrated.
Schema matching algorithms could be applied to guide
the process of mapping between the clinical database
models and the reference ontology. One possible solu-
tion would be to use the platform OpenII [36]. It would
be possible to integrate the OpenII tool into IPTrans
data integration methodology.
In terms of clinical information, it would be important
to extend the Clinical Module to allow importation of
data that follow health information standards like HL7.
It would also be important to provide support to
DICOM medical image standard. Another aspect would
be a security module to implement anonymization
algorithms.
Conclusions
Turning knowledge generated by sciences in a real bene-
fit to enhance human health is one of main goals of
translational research in medicine. To make this real, a
computing infrastructure is required to support storage,
management, integration and analysis of both biological
and clinical information.
The presented approach aims to take a step toward
this infrastructure, proposing a computational platform
that enables the representation of clinical, socio-
demographic and biological information in a integrative
database, supported by an ontological environment in a
flexible and robust way. This platform was designed with
a four level architecture: data level, semantic level, appli-
cation level and user interface level.
Chado biodatabase model was extended to include a
module for representing clinical information. Through
the proposed clinical information module different clin-
ical databases can be adapted and integrated. The real
benefit of adopting a generic model for information rep-
resentation becomes concrete with the emergence of
various applications and analysis tools that are
constructed and maintained by the community that
adopts this model. It also facilitates the integration of
applications and the exchange of data between research
groups and also for research groups that do not adopt
Chado and may wish to use it after the proposed
extension.
The adoption of Chado as the basic model of bio-
logical database allows the reuse of the existing tools
built from Chado or adapted to it through bridge
layers for analysis and visualization of molecular data.
With the proposal of the Clinical Module, this
solution becomes a robust way to practice transla-
tional medicine.
By the use of an ontological approach, through build-
ing the semantic level, it is possible to manage and inte-
grate highly heterogeneous data types such as the
clinical and socio-demographic data. The common refer-
ence ontology acts as a conceptual framework, enabling
the mapping of clinical information from different
sources to a unique reference.
The practical use of this platform with the real use
case demonstrated the feasibility of the integration pro-
posal, highlighting its characteristics of flexibility and
robustness.
Through this computational framework we are giving
a new step to fulfill the technological gap that exists be-
tween the bench and bedside, allowing the reuse of bio-
informatics tools and also enabling a flexible way to
integrate different sources of clinical and socio-
demographic information.
Availability
The Clinical Module and the instructions to import this
approach can be obtained in http://dcm.ffclrp.usp.br/
caib/pg=iptrans. It is recommended to use a fresh install
of Chado model in a PostgreSQL relational database.
Figure 8 Clinical database bridge layer. Clinical database Bridge
Layers are generated from clinical database models stored in CV
module and represent the original structure of the sources which
are used to adapt legacy applications.
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